Simplex Trading
AGIO icon

Simplex Trading’s Agios Pharmaceuticals AGIO Stock Holding History

Simplex Trading’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$355K Sell
10,500
-35,900
-77% -$1.02M ﹤0.01% 3644
2025
Q4 		$1.26M Buy
46,400
+31,900
+220% +$1.12M ﹤0.01% 2401
2025
Q3 		$582K Buy
14,500
+14,300
+7,150% +$538K ﹤0.01% 3635
2025
Q2 		$6K Buy
+200
New +$6.06K ﹤0.01% 7610
2025
Q1 		– Sell
-500
Closed -$16K – 8400
2024
Q4 		$16K Sell
500
-2,000
-80% -$94K ﹤0.01% 6836
2024
Q3 		$111K Sell
2,500
-18,100
-88% -$822K ﹤0.01% 5118
2024
Q2 		$888K Buy
20,600
+18,200
+758% +$657K ﹤0.01% 3040
2024
Q1 		$70K Buy
2,400
+2,300
+2,300% +$61.6K ﹤0.01% 5947
2023
Q4 		$2K Sell
100
-40,500
-100% -$908K ﹤0.01% 8202
2023
Q3 		$1M Buy
40,600
+5,800
+17% +$153K ﹤0.01% 2652
2023
Q2 		$985K Buy
34,800
+13,100
+60% +$326K ﹤0.01% 2613
2023
Q1 		$498K Sell
21,700
-33,200
-60% -$882K ﹤0.01% 3268
2022
Q4 		$1.54M Sell
54,900
-64,500
-54% -$1.82M ﹤0.01% 2073
2022
Q3 		$3.38M Buy
119,400
+80,700
+209% +$2.16M ﹤0.01% 1511
2022
Q2 		$857K Buy
38,700
+32,000
+478% +$723K ﹤0.01% 2794
2022
Q1 		$195K Sell
6,700
-2,900
-30% -$88.6K ﹤0.01% 5186
2021
Q4 		$315K Sell
9,600
-12,800
-57% -$515K ﹤0.01% 4486
2021
Q3 		$1.26M Hold
22,400
– – ﹤0.01% 2758
2021
Q2 		$1.23M Buy
22,400
+22,070
+6,688% +$1.23M ﹤0.01% 2813
2021
Q1 		$1.7M Sell
330
-3
-0.9% -$149 ﹤0.01% 1790
2020
Q4 		$1.44M Buy
333
+295
+776% +$11.7K ﹤0.01% 2124
2020
Q3 		$133K Sell
38
-12
-24% -$526 ﹤0.01% 4585
2020
Q2 		$267K Sell
50
-21
-30% -$972 ﹤0.01% 3665
2020
Q1 		$251K Sell
71
-410
-85% -$18.9K ﹤0.01% 3328
2019
Q4 		$2.3M Sell
481
-352
-42% -$13.3K 0.01% 1365
2019
Q3 		$2.7M Buy
833
+213
+34% +$8.82K 0.01% 1092
2019
Q2 		$3.09M Buy
620
+50
+9% +$2.67K 0.01% 992
2019
Q1 		$3.84M Buy
570
+72
+14% +$4.19K 0.01% 859
2018
Q4 		$2.3M Buy
498
+142
+40% +$8.77K 0.01% 990
2018
Q3 		$2.75M Sell
356
-26
-7% -$2.09K 0.01% 994
2018
Q2 		$3.22M Buy
382
+99
+35% +$8.63K 0.01% 808
2018
Q1 		$21K Buy
283
+165
+140% +$12.8K ﹤0.01% 3295
2017
Q4 		$108K Buy
118
+60
+103% +$3.77K ﹤0.01% 1739
2017
Q3 		$11K Sell
58
-32
-36% -$1.92K ﹤0.01% 3660
2017
Q2 		$55K Sell
90
-23
-20% -$1.18K ﹤0.01% 2297
2017
Q1 		$19K Buy
113
+59
+109% +$2.83K ﹤0.01% 3285
2016
Q4 		$10K Sell
54
-646
-92% -$33.9K ﹤0.01% 3710
2016
Q3 		$149K Buy
700
+609
+669% +$26.5K 0.01% 1244
2016
Q2 		$154K Buy
91
+80
+727% +$3.95K 0.01% 1173
2016
Q1 		$69K Buy
11
+7
+175% +$299 0.01% 1660
2015
Q4 		$1K Sell
4
-35
-90% -$2.29K ﹤0.01% 4756
2015
Q3 		$54K Sell
39
-61
-61% -$5.96K ﹤0.01% 1927
2015
Q2 		$25K Buy
100
+95
+1,900% +$10.2K ﹤0.01% 2256
2015
Q1 		$5K Sell
5
-176
-97% -$19.7K ﹤0.01% 3460
2014
Q4 		$12K Buy
+181
New +$16.2K ﹤0.01% 2437

Other funds holding AGIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Simplex Trading's AGIO Position: Q1 2026 in Review

Simplex Trading increased its Agios Pharmaceuticals (AGIO) stake by 503% in Q1 2026, buying an estimated $886K and bringing the position to 37,462 shares worth $1.27M. The position accounts for ﹤0.01% of the portfolio, ranked #2250.

Simplex Trading first reported a position in AGIO in Q4 2014 and has held it in 28 quarters since. The position peaked at $2.08M in Q2 2018. 232 funds tracked by Wall St. Rank hold AGIO as of Q1 2026.

  • Simplex Trading held 37,462 shares of Agios Pharmaceuticals worth $1.27M as of Q1 2026.
  • Simplex Trading bought 31,253 Agios Pharmaceuticals shares in Q1 2026, an estimated $886K.
  • Agios Pharmaceuticals made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #2250 holding.
  • Simplex Trading first reported a position in Agios Pharmaceuticals in Q4 2014 and has held it in 28 quarters since.
  • Simplex Trading's Agios Pharmaceuticals position peaked at $2.08M in Q2 2018.
  • 232 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.